Clinical Trial Update: Efficacy and Safety of FORRAD® for the Management of Radiation-induced Mucositis in Patients With Nasopharyngeal Carcinoma Receiving IMRT [Phase 2]

View source ↗

Summary

An ongoing Phase 2 trial evaluating FORRAD for radiation-induced mucositis in patients with nasopharyngeal carcinoma undergoing IMRT; no efficacy or safety resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma
• Stomatitis

Drugs mentioned

• FORRAD

Snippet

Sponsor: Yun-fei Xia | Conditions: Nasopharyngeal Neoplasms, Stomatitis | Phase 2 | Status: UNKNOWN